Dr. Shineman is director for scientific affairs at the Alzheimer’s Drug Discovery Foundation, where she develops and manages the Foundation’s drug discovery and development grant programs and strategic initiatives. The ADDF works strategically with foundations, government and industry partners to tackle unmet needs. Projects funded by the ADDF have garnered nearly $2 billion in follow-on funding. Diana joined the ADDF in 2008. She has authored numerous articles and peer-reviewed publications and maintains various professional memberships. She earned a Ph.D.
Anna Shadman is the compound development team leader for Janssen Alzheimer Immunotherapy R&D LLC (Janssen AI), leading the development strategy and execution of the Alzheimer’s Immunotherapy Program portfolio of compounds within an alliance. She is also the site head for San Francisco and a member of the Janssen AI board of directors. She joined Johnson & Johnson in 2005, holding leadership positions in Janssen Global Clinical Operations and Janssen AI, overseeing operational activities for complex Alzheimer’s clinical trials.
Monica Parker is an assistant professor of medicine in the Division of Geriatrics and Gerontology at Emory University. She is also an Education Core Member of Emory’s Alzheimer’s Disease Research Center. She recently received a NIH minority supplement award to study dementia in ethnic persons. She is a co-principal investigator on a $3.5 million NIH grant to the Emory School of Nursing on a study of promoting health and well-being in African American dementia caregivers. A board-certified physician, Dr.
Glenda MacMullin is chief operating officer/chief financial officer for the Consumer Electronics Association, a U.S. trade association representing more than 2,000 companies and that owns and produces the world’s most important technology event, the International Consumer Electronics Show. She joined CEA in 2004 as chief financial officer and since then has added IT management, building operations, HR, legal, membership and the CEA Foundation to her responsibilities. Previously she was director of financial operations for the American Bar Association’s Washington, DC office.
At USC’s School of Pharmacy, Dr. Brinton leads the Brinton Neuroscience Research Laboratory, which pursues basic science and preclinical translational research. She is the R. Pete Vanderveen Chair in Therapeutic Discovery and Development and a Professor of Pharmacology and Pharmaceutical Sciences, Biomedical Engineering and Neurology. She is also director of the Norris Foundation Laboratory for Neuroscience Research. Dr.
Maribeth Bersani has worked in the field of aging for 30 years. Currently she is Interim CEO and Senior Vice President of Public Policy for the Assisted Living Federation of America. ALFA is the largest trade association representing assisted living providers. Prior to joining ALFA, Ms. Bersani worked for Sunrise Senior Living for ten years. During her tenure at Sunrise, she worked in Sunrise development, operations, and regulatory affairs. After opening and managing a new Sunrise Community in Alexandria Virginia, Ms.
Bobbie Ann Brinegar is an experienced nonprofit executive skilled in organizational development, with a history of creating new programs and building successful broad-based coalitions. Before joining OWL, she led initiatives to ensure fair and transparent election procedures and reliable and secure voting systems, and served as a strategic consultant to nonprofit and faith-based organizations. A passionate supporter of her communities, she raised nearly $1 million to provide disaster relief for Florida families hit by Hurricane Andrew.
Dr. Kate Zhong is the Senior Director of Clinical Research for the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas, Nevada, Cleveland, Ohio and Weston, Florida. With a passion for discovery and commitment to bring the best treatment to patients, she is leading the clinical research team conducting urgently needed trials to advance the prevention, early detection and treatment for Alzheimer’s disease, Parkinson’s disease, multiple sclerosis and Huntington’s disease. With more than 30 drugs and diagnostic trials being conducted at the center, Dr.
Beth Roberts is Chief Operating Officer, Universal Cable Productions and Executive Vice President, Business Affairs, NBCUniversal Cable Entertainment and Cable Studios.
In her current position, Roberts oversees operational responsibilities for the strategic and financial growth of Universal Cable Productions. Additionally, Roberts identifies key strategic initiatives in the areas of content creation and business development for the studio as well as managing day-to-day operations. She continues to be part of the studio’s four-person management team.
Nancy Lynn was appointed Senior Vice President of the Arnold P. Gold Foundation (APGF) in January 2014. The APGF’s mission is to optimize the experience and outcomes of health care for both patients and practitioners by promoting care that is as humane as it is technologically sophisticated. The Foundation works with physicians in training and in practice, as well as other members of the healthcare team, to create a culture of respect, dignity and compassion for patients and professionals. Prior to joining the APGF, Ms.